Nicole M Zimmerman (Nicole Zimmerman)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Respiratory Syncytial Virus

Affordable Care Act

Top Venues

Human vaccines & immunotherapeutics

Journal of medical economics

Future oncology (London, England)

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics 19 (1) (2023)
Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics 19 (1) (2023)
Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics 19 (1) (2023)
Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics 19 (1) (2023)
Stuart L Silverman, Elizabeth R Packnett, Anthony Zagar, Sheena Thakkar, Patricia Schepman, Warachal Faison, Cory Hultman, Nicole M Zimmerman, Rebecca L Robinson
Racial variation in healthcare resource utilization and expenditures in knee/hip osteoarthritis patients: A retrospective analysis of a Medicaid population. Journal of medical economics (2023)
Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics 19 (1) (2023)
Elizabeth R Packnett, Nicole M Zimmerman, Patricia Novy, Laura C Morgan, Nnenna Chime, Parinaz K Ghaswalla
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis. Human vaccines & immunotherapeutics (2023)
Jason R Gantenberg, Robertus van Aalst, Nicole M Zimmerman, Brendan Limone, Sandra S Chaves, William V La Via, Christopher B Nelson, Christopher Rizzo, David A Savitz, Andrew R Zullo
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020. The Journal of infectious diseases 226 (Suppl 2) (2022)
Andrew Blauvelt, Nianwen Shi, Mwangi J Murage, Scott A Kern, Najwa Somani, Russel T Burge, Terri L Ridenour, Carolyn R Lew, Nicole M Zimmerman, Baojin Zhu
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings. Journal of medical economics 25 (1) (2022)
Nicole M Zimmerman, David Ray, Princic Nicole, Meghan Moynihan, Callisia N Clarke, Alexandria T Phan
Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data. Future oncology (London, England) 17 (24) (2021)
Andrew Blauvelt, Nianwen Shi, Russel T Burge, William N Malatestinic, Chen-Yen Lin, Carolyn R Lew, Nicole M Zimmerman, Orin M Goldblum, Baojin Zhu, Mwangi J Murage
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab. Patient preference and adherence 14 (2020)